MicroRNAs as theranostic markers in cardiac allograft transplantation: from murine models to clinical practice

Congestive heart failure affects about 23 million people worldwide, and cardiac allograft transplantation remains one of the last options for patients with terminal refractory heart failure. Besides the infectious or oncological complications, the prognosis of patients after heart transplantation is...

Descripción completa

Detalles Bibliográficos
Autores principales: Novák, Jan, Macháčková, Táňa, Krejčí, Jan, Bienertová-Vašků, Julie, Slabý, Ondřej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058726/
https://www.ncbi.nlm.nih.gov/pubmed/33897899
http://dx.doi.org/10.7150/thno.56327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058726/
https://www.ncbi.nlm.nih.gov/pubmed/33897899
http://dx.doi.org/10.7150/thno.56327

Ejemplares similares